Bye M R, Ewig J M, Quittell L M
Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
Lung. 1994;172(5):251-70. doi: 10.1007/BF00164308.
While the care of cystic fibrosis (CF) patients has been mainly the province of pediatricians, great improvements in the therapy and life span of CF patients often results in their transition to care by adult physicians. In this review of CF, we begin with an overview of the epidemiology and genetics of the disease, with a discussion of the recently found ion abnormalities that lead to the clinical manifestations. This is followed by a discussion of the pathophysiology. Methods of diagnosis, ranging from the gold standard, the sweat test, to recent advances based on a greater understanding of the genetics of the disease are reviewed. This is followed by a discussion of therapy primarily geared to the treatment of the respiratory complications, as they are the most common lethal factors of the disease. We point out controversies where they exist. Newer forms of therapy such as lung transplantation are discussed, and we finish with a discussion about future therapeutic modalities, some of which are being approved as the paper is in print.
虽然囊性纤维化(CF)患者的护理主要由儿科医生负责,但CF患者治疗方法的巨大改进以及寿命的延长,常常使他们转而由成年医生进行护理。在这篇关于CF的综述中,我们首先概述该疾病的流行病学和遗传学,并讨论最近发现的导致临床表现的离子异常情况。接下来讨论其病理生理学。回顾了诊断方法,从金标准汗液试验到基于对该疾病遗传学更深入理解的最新进展。随后讨论主要针对呼吸并发症治疗的疗法,因为呼吸并发症是该疾病最常见的致命因素。我们指出存在争议的地方。还讨论了肺移植等新的治疗形式,最后我们讨论未来的治疗方式,其中一些在本文付梓之时正在获批。